The interplay between recovery and immunity in infectious and non-communicable diseases.

BACKGROUND

The interplay between recovery and immune responses is increasingly recognized but remains under-integrated in clinical and research frameworks. Recovery extends beyond physiological repair to include restoration of function, psychological adaptation, and social reintegration, while immunity provides dynamic protection and regulation. Emerging evidence suggests that recovery trajectories shape immune competence and long-term resilience.

SCOPE AND APPROACH: This review synthesizes evidence on bidirectional recovery-immunity interactions across infectious and non-communicable diseases (NCDs). We examine immune- linked mechanisms of inflammation resolution, tissue repair/regeneration, and functional restoration, and discuss how recovery states feedback to immune competence. Illustrative contexts include viral, bacterial, parasitic, and fungal infections, as well as cancer, autoimmune, metabolic, cardiovascular, and neurodegenerative disorders.

KEY FINDINGS: Shared pathways connecting recovery and immunity include cytokine signaling, macrophage polarization, and regenerative programs. Recovery outcomes are further modified by host and contextual factors such as genetics, aging, nutrition, comorbidities, and psychosocial stress. Clinical and translational approaches, such as immunotherapy, rehabilitation, vaccination, and precision medicine, offer practical ways to support recovery, but they must be applied with careful attention to the immune trade-offs they may introduce. Advances in biomarkers, multi- omics profiling, and AI-enabled modeling offer promising tools to quantify recovery phenotypes and predict immune resilience.

CONCLUSION

Positioning recovery as an active immunological state enables more coherent frameworks for understanding disease trajectories and guiding interventions. Integrating recovery biology with immune regulation may enhance patient outcomes and support durable, resilient health across diverse disease settings.